CT
Thouverey, Cyril
Affiliation entities
Research groups
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Sclerostin blockade inhibits bone resorption through PDGF receptor signaling in osteoblast lineage cells | JCI insight | 2024 | 115 | 110 | |||
| Reduced sclerostin expression in human atherosclerotic plaques links to ischemic stroke | Journal of the American Heart Association. Cardiovascular and cerebrovascular disease | 2024 | 79 | 43 | |||
| Primary mouse osteoblast and osteoclast culturing and analysis | STAR protocols | 2021 | 420 | 286 | |||
| PDGF receptor signaling in osteoblast lineage cells controls bone resorption through upregulation of csf1 expression | Journal of Bone and Mineral Research | 2020 | 289 | 1 | |||
| Selective inhibition of Src family kinases by SU6656 increases bone mass by uncoupling bone formation from resorption in mice | Bone | 2018 | 463 | 3 | |||
| Suppression of p38α MAPK Signaling in Osteoblast Lineage Cells Impairs Bone Anabolic Action of Parathyroid Hormone | Journal of bone and mineral research | 2016 | 391 | 4 | |||
| Sclerostin inhibits osteoblast differentiation without affecting BMP2/SMAD1/5 or Wnt3a/β-catenin signaling but through activation of platelet-derived growth factor receptor signaling in vitro | BoneKEy reports | 2015 | 467 | 7 | |||
| Ablation of p38α MAPK Signaling in Osteoblast Lineage Cells Protects Mice From Bone Loss Induced by Estrogen Deficiency | Endocrinology | 2015 | 466 | 3 | |||
| Focus on the p38 MAPK signaling pathway in bone development and maintenance | BoneKEy reports | 2015 | 611 | 4 | |||
| Crosstalk between tyrosine kinase receptors, GSK3 and BMP2 signaling during osteoblastic differentiation of human mesenchymal stem cells | Molecular and cellular endocrinology | 2014 | 679 | 1 | |||
| Predominant role of PDGF receptor transactivation in Wnt3a-induced osteoblastic cell proliferation | Journal of bone and mineral research | 2013 | 684 | 500 | |||
| Fibroblast growth factor 2 inhibits up-regulation of bone morphogenic proteins and their receptors during osteoblastic differentiation of human mesenchymal stem cells | Biochemical and biophysical research communications | 2012 | 566 | 0 | |||
| The p38α MAPK positively regulates osteoblast function and postnatal bone acquisition | Cellular and molecular life sciences | 2012 | 599 | 477 | |||
| Activation of FGF receptors is a new mechanism by which strontium ranelate induces osteoblastic cell growth | Cellular physiology and biochemistry | 2011 | 654 | 444 | |||
| Discovering the multiple roles of the p38 pathway in bone biology | IBMS boneKEy | 2010 | 606 | 1 |
